Events Add an event Speakers Talks Collections
 

Speakers

Sort by
Newest
Trending
1-27 of 27
1-27 of 27
Filter
David Downs
California Bureau Chief at Leafly.com
americans for safe access, asa unity, brand, cannabidiol, cannabis, cannabis (drug), cannabis conference 2021, cannabis in washington, d.c., centers for disease control and prevention, dietary supplement, disease, dronabinol, drug enforcement administration, electoral impact, electronic cigarette, food and drug administration, good manufacturing practice, health canada, legislative advocacy, marijuana, marijuana conference 2021, medical cannabis, medication, occupational safety and health, patients right advocacy, pharmacy, police, property, regulatory compliance, safety, severe acute respiratory syndrome coronavirus 2, tetrahydrocannabinol, unity2021, vaporizer (inhalation device)
Elan Sudberg
CEO at Alkemist Labs
americans for safe access, asa unity, brand, cannabidiol, cannabis, cannabis (drug), cannabis conference 2021, cannabis in washington, d.c., centers for disease control and prevention, dietary supplement, disease, dronabinol, drug enforcement administration, electoral impact, electronic cigarette, food and drug administration, good manufacturing practice, health canada, legislative advocacy, marijuana, marijuana conference 2021, medical cannabis, medication, occupational safety and health, patients right advocacy, pharmacy, police, property, regulatory compliance, safety, severe acute respiratory syndrome coronavirus 2, tetrahydrocannabinol, unity2021, vaporizer (inhalation device)
Sheri Tarr
Chief Advisor and Founder at 68PARTNER
americans for safe access, asa unity, brand, cannabidiol, cannabis, cannabis (drug), cannabis conference 2021, cannabis in washington, d.c., centers for disease control and prevention, dietary supplement, disease, dronabinol, drug enforcement administration, electoral impact, electronic cigarette, food and drug administration, good manufacturing practice, health canada, legislative advocacy, marijuana, marijuana conference 2021, medical cannabis, medication, occupational safety and health, patients right advocacy, pharmacy, police, property, regulatory compliance, safety, severe acute respiratory syndrome coronavirus 2, tetrahydrocannabinol, unity2021, vaporizer (inhalation device)
Pavel Pachta
International Regulatory Affairs Director at ICCI - International Cannabis and Cannabinoids Institute
marijuana therapeutics and research, adherence (medicine), americans for safe access, asa conference, asa unity, asa unity 2021, cannabis, cannabis conference 2021, chronic pain, clinical trial, dose (biochemistry), drug enforcement administration, drug prohibition law, emergency department, food and drug administration, health care, health economics, international narcotics control board, marijuana, marijuana conference 2021, medical cannabis, medical cannabis education, medicare (united states), medication, obesity, opioid, opioid epidemic, pain, pharmacology, pharmacy, pit bull, prohibition of drugs, substance dependence, tax, unity2021, welfare
Steph Sherer
Executive Director at Americans For Safe Access
cannabis company washington, d.c., marijuana therapeutics and research, adherence (medicine), americans for safe access, asa conference, asa unity, asa unity 2021, asus, cannabis, cannabis (drug), cannabis 2021, cannabis conference 2021, cannabis washington, d.c., charlotte figi, chronic pain, clinical trial, community, covid-19 pandemic, dispensary, dose (biochemistry), drug enforcement administration, drug prohibition law, emergency department, food and drug administration, health care, health economics, international narcotics control board, ipod classic, la la land, language, law, legal access to cannabis, legislative advocacy, lgbt community, marijuana, marijuana conference 2021, marijuana policy project, medical cannabis, medical cannabis education, medicaln marijuana, medicare (united states), medication, obesity, opioid, opioid epidemic, organization, pain, pandemic, patient, pharmacology, pharmacy, pit bull, presidency, prohibition of drugs, reggae, rights, san diego, substance dependence, tax, united states, united states congress, unity2021, usb, welfare
Elias Theodorou
Professional MMA Athlete at The UFC
anderson silva, beer, burden of proof (law), canmar recruitment, canmarexpo, cannabidiol, cannabis, cannabis (drug), cannabis careeres, cannabis industry, cannabis industry recruitment , cannabis jobs agency, cannabis recruitment, crime, decriminalization of non-medical cannabis in the united states, doping in sport, drink, drug, drug rehabilitation, hr in cannabis industry, human resources, medical cannabis, medication, mixed martial arts, neurology, nick diaz, opiate, persecution, propaganda, social stigma, sport, tetrahydrocannabinol, tetrahydrocannabinolic acid, vaporizer (inhalation device), war on drugs
Justin Roethlingshoefer
Founder at Own It
anderson silva, beer, burden of proof (law), canmar recruitment, canmarexpo, cannabidiol, cannabis, cannabis (drug), cannabis careeres, cannabis industry, cannabis industry recruitment , cannabis jobs agency, cannabis recruitment, crime, decriminalization of non-medical cannabis in the united states, doping in sport, drink, drug, drug rehabilitation, hr in cannabis industry, human resources, medical cannabis, medication, mixed martial arts, neurology, nick diaz, opiate, persecution, propaganda, social stigma, sport, tetrahydrocannabinol, tetrahydrocannabinolic acid, vaporizer (inhalation device), war on drugs
Michael Chang
Medical Director at Nutex Health
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Joseph Rosado
Physician and Medical Director at International Medical Consultants and Cannabidiol Life
adalimumab, alzheimer's disease, analgesic, anti-inflammatory, anticoagulant, antipsychotic, appetite, arthritis, autoimmune disease, benzodiazepine, bioavailability, bipolar disorder, bleeding, brand, bronchodilator, budtender, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis industry, cannabis sativa, cannabis strain, cerebellum, certificate of analysis, chemical synapse, chronic condition, chronic fatigue syndrome, depression (mood), diabetes, dispensary, dopamine, dose (biochemistry), dravet syndrome, drug, drug enforcement administration, drug overdose, edema, education, effects of cannabis, emergency department, emergency medical technician, endocannabinoid system, epilepsy, family medicine, fibromyalgia, food and drug administration, free market, gateway drug effect, good manufacturing practice, gpr55, hair loss, heartburn, hiv, homeostasis, hydroxychloroquine, hypertension, indication (medicine), insomnia, irritable bowel syndrome, lupus, medical cannabis, medical prescription, medical school, medication, medicine, mental disorder, mental health, methotrexate, morphine, national health service, nervous system, norepinephrine, nursing, omega-6 fatty acid, opiate, opioid, oxycodone, oxycodone/paracetamol, pain management, paracetamol, paramedic, parkinson's disease, pediatrics, peripheral neuropathy, personalized medicine, pharmaceutical industry, pharmacology, pharmacy, physician, placebo, placebo-controlled study, post-traumatic stress disorder, prescription drug, psilocybin mushroom, psychological trauma, pulmonary fibrosis, randomized controlled trial, residency (medicine), rhabdomyosarcoma, rheumatoid arthritis, schizophrenia, self-medication, serotonin, spasticities, sports medicine, sympathetic nervous system, symptom, synapse, syndrome, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, tony montana, topical medication, transgenerational trauma, vagus nerve, vagus nerve stimulation, vaporizer (inhalation device), warfarin
Jeff Konin
Clinical Professor at College of Nursing & Health Sciences at Florida International University
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Kevin Carrillo
Chief Operating Officer at Cannabinoid Nation
advertising, arthritis, audience measurement, blog, brand, brand awareness, budtender, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis edible, chocolate, coca-cola, contract, dietary supplement, digital marketing, effects of cannabis, emergency department, endocannabinoid system, facebook, fibromyalgia, food, food science, game balance, google, google search, gpr55, hashtag, homeostasis, hot chocolate, hydroxychloroquine, instagram, internet, linkedin, liquid, medical school, medicine, minimum viable product, money, morphine, news, newspaper, opiate, pay to play, pepsi, placebo, product sample, psilocybin mushroom, randomized controlled trial, research, search engine optimization, shelf life, small business, social media, social media marketing, sports medicine, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, twitter, vaporizer (inhalation device), whole foods market, yeast, youtube
Tyler Robson
CEO at The Valens Company
australia, business model, canada, cannabis, cannabis edible, cannabis extraction, cse:vgw, drink, ethanol, europe, fee-for-service, fly, gel, hydrocarbon, investing, license, money, news, otcqb:vgwcf, petroleum, stocks, tincture, tsxv:vgw, united states, valens, valens groworks, vaporizer (inhalation device)
Greg Engel
CEO at OrganiGram Inc.
canada, cannabidiol, cannabinoid, cannabis, cannabis investing, cannabis stocks, diversification (finance), earnings before interest, taxes, depreciation and amortization, emergence, food, greg engel, hemp, interest, investing, investor, leverage (finance), lift & co., lift & co. cannabis expo, m&m's, marijuana investing, marijuana stocks, market (economics), market liquidity, marketplace, nasdaq:ogi, news, organigram holdings, otc markets group, pharmacy, retail, stock, stocks, sustainability, tetrahydrocannabinol, tsxv:ogi, united states, vaporizer (inhalation device), yeast
Jessica Lower
Senior Analyst at True Science Laboratories
california, cannabidiol, cannabis (drug), certificate of analysis, counterfeit consumer goods, dose (biochemistry), electronic cigarette, farmer, fertilizer, health care, hemp, nothing, organic farming, overtime, packaging and labeling, packaging, and labeling, patient, pharmaceutical industry, plastic, retail, shelf life, supply chain, titanium, traceability, vaporizer (inhalation device), water content
James Schwartz
CEO at Cascade High
agriculture, antibiotic, aromatherapy, bacteria, bank, brand, california, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis sativa, certificate of analysis, charlotte's web (cannabis), clinical trial, coeliac disease, compost, convenience store, counterfeit consumer goods, crop insurance, curriculum, dietary supplement, distribution (marketing), dose (biochemistry), due diligence, ecosystem, electronic cigarette, endocannabinoid system, endocrine system, evidence-based medicine, farmer, fertilizer, finance, food, food and drug administration, gardening, gene, genetically modified crops, genetically modified food, genetically modified organism, genetics, gluten, gluten-related disorders, glyphosate, glyphosates, go to market, good manufacturing practice, health care, hemp, homeostasis, integrated pest management, irritable bowel syndrome, lawyer, maize, mediation, medical cannabis, medical prescription, medication, natural environment, nervous system, nothing, online advertising, organic certification, organic farming, organic matter, organized crime, overtime, packaging and labeling, packaging, and labeling, pain management, pansy, password, patient, payment, pest control, pesticide, pharmaceutical industry, placebo-controlled study, plant breeding, plastic, prescription drug, pricing, psychoactive drug, question, recycling, retail, safety, sampling (statistics), self-medication, shelf life, smoking, social media, soil, supply chain, sustainability, sustainable agriculture, sympathetic nervous system, tetrahydrocannabinol, titanium, tomato, traceability, tree, united states department of agriculture, united states postal service, vaporizer (inhalation device), water content
Josh Pearl
Founder and Chief Scientist at Gruene Cross Health and Wellness
behavior, brand, california, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), certificate of analysis, commodity, counterfeit consumer goods, dose (biochemistry), electronic cigarette, entourage effect, farmer, fertilizer, genetically modified food, health care, hemp, herbicide, insomnia, nothing, nsf international, organic certification, organic farming, overtime, packaging and labeling, packaging, and labeling, pain, patient, pharmaceutical industry, plastic, price, retail, shelf life, solution, supply chain, tetrahydrocannabinol, titanium, tobacco, traceability, vaporizer (inhalation device), warren buffett, water content
Antonio Frazer
VP of Operations at CannaSafe
california, cannabidiol, cannabis (drug), certificate of analysis, counterfeit consumer goods, dose (biochemistry), electronic cigarette, farmer, fertilizer, health care, hemp, nothing, organic farming, overtime, packaging and labeling, packaging, and labeling, patient, pharmaceutical industry, plastic, retail, shelf life, supply chain, titanium, traceability, vaporizer (inhalation device), water content
Tamar Wise
CEO and Founder; Lead Cannabis Science and Busines at Wise Science Consulting
animal testing, aromatherapy, cannabidiol, cannabinoid, cannabis, chemotherapy, dose (biochemistry), electric battery, electronic cigarette, entourage effect, essential oil, food and drug administration, glyphosate, herb, medication, natural product, odor, olfaction, over-the-counter drug, perfume, personalized medicine, solvent, tetrahydrocannabinol, vaporizer (inhalation device), water
Jake Black
Chief Scientific Officer at Treehouse Biotech
accuracy and precision, analgesic, anesthesia, animal testing, aromatherapy, attention, big data, biochemistry, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis sativa, cannabis strain, carbon dioxide, carboxylic acid, cell (biology), certificate of analysis, certification, chemistry, chemotherapy, chromatography, circulatory system, cocaine, court, data, dietary supplement, dose (biochemistry), drug overdose, drug rehabilitation, drug test, electric battery, electronic cigarette, endocannabinoid system, entourage effect, enzyme, essential oil, ethanol, food, food and drug administration, fungus, gas chromatography, glyphosate, greenhouse gas, hemp, herb, herbal medicine, inquiry, international organization for standardization, iso/iec 17025, kashrut, life, lipid bilayer, major depressive disorder, mass, measurement uncertainty, medical cannabis, medication, mercury (element), mood (psychology), mood disorder, natural product, nutrient, odor, olfaction, opiate, opioid, over-the-counter drug, pain, pain management, parts-per notation, perfume, personalized medicine, pesticide, pesticide residue, pharmaceutical industry, pharmacology, placebo, prescription drug, product liability, propagation of uncertainty, protein structure, protein structures, protein-protein interaction, protein–protein interaction, quantification (science), regulatory compliance, reliability engineering, reputation, research, science, solvent, stress (biology), substance dependence, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinol acid, traceability, uncertainty, united states pharmacopeia, validity (statistics), vaporizer (inhalation device), vitamin, water, whole foods market
Wendy Pagaduan
Founder & Owner at Clean Cocon ut
animal testing, aromatherapy, cannabidiol, cannabinoid, cannabis, chemotherapy, dose (biochemistry), electric battery, electronic cigarette, entourage effect, essential oil, food and drug administration, glyphosate, herb, medication, natural product, odor, olfaction, over-the-counter drug, perfume, personalized medicine, solvent, tetrahydrocannabinol, vaporizer (inhalation device), water
Susan Trapp
Chief Research Officer at EndoSyn
animal testing, aromatherapy, cannabidiol, cannabinoid, cannabis, chemotherapy, dose (biochemistry), electric battery, electronic cigarette, entourage effect, essential oil, food and drug administration, glyphosate, herb, medication, natural product, odor, olfaction, over-the-counter drug, perfume, personalized medicine, solvent, tetrahydrocannabinol, vaporizer (inhalation device), water
Stephen Goldman
Laboratory Director at PhytaTech
american chemical society, animal testing, aromatherapy, automation, azoxystrobin, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis sativa, chemist, chemistry, chemotherapy, detection limit, dna sequencing, dose (biochemistry), eating, education, electric battery, electronic cigarette, entourage effect, essential oil, food and drug administration, food safety, gene, genetics, genomics, glyphosate, good manufacturing practice, hemp, herb, interdisciplinarity, learning, life-cycle assessment, medication, microbiota, mold, molds, mycotoxin, natural product, natural resource, news, nonprofit organization, odor, olfaction, over-the-counter drug, perfume, personalized medicine, polymerase chain reaction, primer (molecular biology), reason, regulatory risk differentiation, research and development, research, and development, risk, social stigma, solvent, sugar, technology, tetrahydrocannabinol, time, topical medication, vaporizer (inhalation device), vegetable, verification, and validation, videotelephony, water
Kevin Koby
Chief Scientific Officer at Abstrax Tech
alternative medicine, amphetamine, animal testing, antioxidant, attention deficit hyperactivity disorder, bioavailability, breathing, cannabinoid, cannabis, chylomicron, cytochrome p450, digestion, dose (biochemistry), drug test, enzyme, intravenous therapy, medical cannabis, medication, medicine, pharmacogenomics, pharmacokinetics, physician, science, tetrahydrocannabinol, vaporizer (inhalation device)
Steven Bennett
Founder and Chief Scientific Officer at Prescott Logic Technologies Ltd.
alternative medicine, amphetamine, animal testing, antioxidant, attention deficit hyperactivity disorder, bioavailability, brand, breathing, business model, cannabidiol, cannabinoid, cannabis, cannabis (drug), chylomicron, classified information, clinical trial, conversation, cytochrome p450, digestion, dose (biochemistry), drug, drug test, enzyme, facebook, food and drug administration, hashish, hemp, instagram, intravenous therapy, intrinsic safety, lobbying in the united states, market (economics), marketplace, median lethal dose, medical cannabis, medical prescription, medication, medicine, nutraceutical, over-the-counter drug, pepsi, pharmacogenomics, pharmacokinetics, pharmacology, physician, prescription drug, pressure vessel, reality, receptor (biochemistry), receptor antagonist, reputation, retail, science, shelf life, shore durometer, social media, tax, tetrahydrocannabinol, theory, understanding, vaporizer (inhalation device), washing machine, word-of-mouth marketing, xfinity
A.J. Herrington
Freelance Writer at High Times, Merry Jane, Sensi, HEMP
alternative medicine, amphetamine, animal testing, antioxidant, attention deficit hyperactivity disorder, bioavailability, breathing, cannabinoid, cannabis, chylomicron, cytochrome p450, digestion, dose (biochemistry), drug test, enzyme, intravenous therapy, medical cannabis, medication, medicine, pharmacogenomics, pharmacokinetics, physician, science, tetrahydrocannabinol, vaporizer (inhalation device)
David Gordon
Owner at 4 Pillars Health & Wellness
alternative medicine, amphetamine, animal testing, anti-inflammatory, antioxidant, attention deficit hyperactivity disorder, bioavailability, bong, breathing, cannabidiol, cannabinoid, cannabis, cannabis (drug), chylomicron, cytochrome p450, digestion, dispensary, dose (biochemistry), drug test, enzyme, intravenous therapy, kentucky, medical cannabis, medical school, medication, medicine, nursing, ondansetron, opiate, over-the-counter drug, pharmacogenomics, pharmacokinetics, physician, prescription drug, psychopharmacology, research, science, social stigma, specialty (medicine), substance abuse, tetrahydrocannabinol, therapy, vaporizer (inhalation device)
Ricardo E Rivera-Acevedo
Chief Science Officer, Adjunct Professor at Ecovita Health Corporation, University Of British Columbia
alternative medicine, amphetamine, anesthesiology, animal testing, antioxidant, attention deficit hyperactivity disorder, automation, bioavailability, biodegradation, brand, breathing, business ethics, cannabidiol, cannabinoid, cannabinol, cannabis, cell membrane, chylomicron, competition, compost, cytochrome p450, dangerous goods, digestion, dose (biochemistry), drug test, electronic cigarette, engineering, environmental remediation, enzyme, good manufacturing practice, hemp, innovation, intravenous therapy, iso 9000, labeling of fertilizer, liquid-liquid extraction, litter, litter box, medical cannabis, medication, medicine, membrane, nanofiltration, nsf international, pesticide, pharmaceutical industry, pharmacogenomics, pharmacokinetics, pharmacology, physician, plastic, pressure vessel, recycling, reputation, risk, safety, science, specification (technical standard), tetrahydrocannabinol, traceability, vaporizer (inhalation device), waste, waste management, water, water purification, water treatment
1
1-27 of 27